Vascular Surgery Workforce: Evaluation and Estimation of Future Demand in the United Kingdom.


Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 01 06 2022
revised: 03 08 2022
accepted: 25 08 2022
pubmed: 21 9 2022
medline: 25 1 2023
entrez: 20 9 2022
Statut: ppublish

Résumé

Vascular disease is a common cause of death and disability in our growing elderly population and the demand for vascular procedures is increasing worldwide. Workforce planning is essential to meet future demand and provide safe vascular services. Our aim was to evaluate the current workforce in the United Kingdom and estimate future demand for vascular surgeons. From November 2020 to January 2021, we surveyed UK vascular surgeons for information on their work patterns. We estimated current vascular surgery (VS) workforce using the National Vascular Registry (NVR) data and population data from the Office for National Statistics. To estimate future demand, we interrogated Hospital Episode Statistic (HES) data using Hospital Admitted Patient Care Activity (HAPCA) and linear trend analysis. NVR data estimate that currently there are 518 consultant VS in the United Kingdom, or 1 per 128,951 population, lower than international comparisons. HAPCA data (2012-2020) suggests VS Finished Consultant Episodes (FCE), admissions, and waiting lists are growing by approximately 2% per year, and we estimate the workforce will need to grow by more than 50% over the next 10 years to meet this demand and Vascular Society of Great Britain and Ireland recommendation. The UK has a shortage of vascular surgeons at a time when vascular activity is increasing. The VS workforce, both VS consultant and vascular surgeons in training numbers need to expand to address the ongoing shortage and maintain a safe level of service.

Sections du résumé

BACKGROUND BACKGROUND
Vascular disease is a common cause of death and disability in our growing elderly population and the demand for vascular procedures is increasing worldwide. Workforce planning is essential to meet future demand and provide safe vascular services. Our aim was to evaluate the current workforce in the United Kingdom and estimate future demand for vascular surgeons.
METHODS METHODS
From November 2020 to January 2021, we surveyed UK vascular surgeons for information on their work patterns. We estimated current vascular surgery (VS) workforce using the National Vascular Registry (NVR) data and population data from the Office for National Statistics. To estimate future demand, we interrogated Hospital Episode Statistic (HES) data using Hospital Admitted Patient Care Activity (HAPCA) and linear trend analysis.
RESULTS RESULTS
NVR data estimate that currently there are 518 consultant VS in the United Kingdom, or 1 per 128,951 population, lower than international comparisons. HAPCA data (2012-2020) suggests VS Finished Consultant Episodes (FCE), admissions, and waiting lists are growing by approximately 2% per year, and we estimate the workforce will need to grow by more than 50% over the next 10 years to meet this demand and Vascular Society of Great Britain and Ireland recommendation.
CONCLUSIONS CONCLUSIONS
The UK has a shortage of vascular surgeons at a time when vascular activity is increasing. The VS workforce, both VS consultant and vascular surgeons in training numbers need to expand to address the ongoing shortage and maintain a safe level of service.

Identifiants

pubmed: 36126835
pii: S0890-5096(22)00518-0
doi: 10.1016/j.avsg.2022.08.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-160

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Aoife Kiernan (A)

Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: aoifekiernan.ak@gmail.com.

Fiona Boland (F)

Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Denis W Harkin (DW)

Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Sarah Alzayyat (S)

Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Áine Ryan (Á)

Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Sophie Renton (S)

North West London Hospitals National Health Service Trust, London, UK.

Lucy Wales (L)

Northern Vascular Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.

Christopher Imray (C)

Department of Vascular Surgery, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH